Axogen (AXGN) Return on Invested Capital (2012 - 2013)
Axogen's quarterly Return on Invested Capital came in at 0.05% in Q4 2013, down 4.0% year-on-year from 0.05% in Q4 2012, and down 229.61% quarter-over-quarter from 0.03% in Q3 2013.
Axogen has reported Return on Invested Capital for 2 years, with the latest figure at 0.05% in Q4 2013.
- For the quarter ending Q4 2013, Return on Invested Capital fell 4.0% year-over-year to 0.05%; the trailing twelve-month figure through Dec 2013 stood at 0.05% (down 4.0% YoY), and the FY2012 full-year result was 0.0%, changed N/A from the prior year.
- Return on Invested Capital for Q4 2013 stood at 0.05%, down from 0.03% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.03% in Q3 2013, with the low at 0.05% in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.00% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.00% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.00% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.00% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.00% |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -0.05% |
| Sep 30, 2013 | 0.03% |
| Jun 30, 2013 | 0.01% |
| Dec 31, 2012 | -0.01% |
| Sep 30, 2012 | -0.01% |